Literature DB >> 14766802

Neuronal apoptotic bodies: phagocytosis and degradation by primary microglial cells.

Alexandra Stolzing1, Tilman Grune.   

Abstract

Neuronal loss via apoptosis is a key element in numerous neurodegenerative diseases. To avoid accumulation of apoptotic material, the remains of apoptotic cells should be degraded. It was suggested that microglial cells are phagocytosing and degrading apoptotic material. There is only limited information available concerning the fate of the remains of apoptotic neurons. In this study, we investigated the ability of microglial cells to take up and degrade neuronal apoptotic material. We isolated primary microglial cells and used apoptotic bodies of apoptotic neuron-like PC12 cells as a substrate. The apoptotic material was taken up and degraded within the microglial cells. The uptake is clearly activation dependent. We were able to demonstrate that the CD36 scavenger receptor is involved in the uptake of the apoptotic material via competition studies, antibody blockage, and use of a CD36 mutant rat strain. Blockage of other uptake mechanisms was also able to inhibit the uptake to some extent. Furthermore, we were able to demonstrate the role of the microglial lysosomal and proteasomal pathways in the degradation of proteins originating from apoptotic bodies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766802     DOI: 10.1096/fj.03-0374fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  33 in total

1.  Elevation of GM2 ganglioside during ethanol-induced apoptotic neurodegeneration in the developing mouse brain.

Authors:  Mitsuo Saito; Goutam Chakraborty; Relish Shah; Rui-Fen Mao; Asok Kumar; Dun-Sheng Yang; Kostantin Dobrenis; Mariko Saito
Journal:  J Neurochem       Date:  2012-03-20       Impact factor: 5.372

2.  Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression.

Authors:  Mariko Noda; Yukiko Doi; Jianfeng Liang; Jun Kawanokuchi; Yoshifumi Sonobe; Hideyuki Takeuchi; Tetsuya Mizuno; Akio Suzumura
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

Review 3.  Microglia biology in health and disease.

Authors:  Gwenn A Garden; Thomas Möller
Journal:  J Neuroimmune Pharmacol       Date:  2006-03-25       Impact factor: 4.147

Review 4.  Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain.

Authors:  Jens Pahnke; Christina Fröhlich; Markus Krohn; Toni Schumacher; Kristin Paarmann
Journal:  Mech Ageing Dev       Date:  2013-09-03       Impact factor: 5.432

Review 5.  Inflammation in the early stages of neurodegenerative pathology.

Authors:  Preeti J Khandelwal; Alexander M Herman; Charbel E-H Moussa
Journal:  J Neuroimmunol       Date:  2011-08-05       Impact factor: 3.478

Review 6.  Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.

Authors:  Xiu-Rong Zhao; Nicole Gonzales; Jaroslaw Aronowski
Journal:  CNS Neurosci Ther       Date:  2014-11-28       Impact factor: 5.243

Review 7.  Pathway analysis of the human brain transcriptome in disease.

Authors:  Tomas Kavanagh; James D Mills; Woojin S Kim; Glenda M Halliday; Michael Janitz
Journal:  J Mol Neurosci       Date:  2012-12-22       Impact factor: 3.444

Review 8.  Clearance of apoptotic cells: implications in health and disease.

Authors:  Michael R Elliott; Kodi S Ravichandran
Journal:  J Cell Biol       Date:  2010-06-28       Impact factor: 10.539

9.  Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice.

Authors:  Sha-Ron Pierre; Marijke A M Lemmens; Maria E Figueiredo-Pereira
Journal:  J Neuroinflammation       Date:  2009-07-25       Impact factor: 8.322

10.  MFG-E8 regulates microglial phagocytosis of apoptotic neurons.

Authors:  Abby D Fuller; Linda J Van Eldik
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.